« Back
Home /
Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)

Monoclonal Antibody to Tumor Necrosis Factor Alpha (TNFa)

Item no.	MAA133Rb21-500ul
Manufacturer	Cloud-Clone
Amount	500 ul
Quantity options	100 ul 1 ml 200 ul 20 ul 500 ul
Category	Oncology Neuroscience Neuroinflammation Metabolism Diabetes Antibodies By Cell Type Cell Biology Obesity Cell Culture Cytokines Cell Status Necrosis Apoptosis Immunohistochemistry Immunoprecipitation Western Blot Immunocytochemistry Primary Antibodies
Type	Antibody Monoclonal
Format	Liquid
Applications	WB, IP, IHC, ICC
Clone	D3
Specific against	Rabbit (Oryctolagus cuniculus)
Host	Mouse
Isotype	IgG2b Kappa
Citations	Increased synovial lipodystrophy induced by high fat diet aggravates synovitis in experimental osteoarthritis.
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	DIF,TNF-A,TNFSF2,Cachectin,Tumor Necrosis Factor Ligand Superfamily Member 2
Available
Manufacturer - Category	Primary Ab
Manufacturer - Research Area	Cytokine, Tumor immunity, Infection immunity,
Buffer Formulation	PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Immunogen	RPA133Rb01-Recombinant Tumor Necrosis Factor Alpha (TNFa)
Usage	Western blotting: 0.01-3µg/mL; < br/> Immunohistochemistry: 5-30µg/mL; < br/> Immunocytochemistry: 5-30µg/mL; < br/> Optimal working dilutions must be determined by end user.
Purification	Protein A + Protein G affinity chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.